Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
Gaetano Aurilio(European Institute of Oncology), Rodolfo Montironi(Marche Polytechnic University), Alessia Cimadamore(University of Udine), Francesco Massari(Altera (United States)), Roberta Mazzucchelli(University of Foggia), Marina Scarpelli(Marche Polytechnic University), Liang Cheng(Brown University), Elena Verri(European Institute of Oncology), Antonio López-Beltrán(University of Córdoba), Matteo Santoni(University of Macerata)
Cited by 256
Related Papers
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
|Modern Pathology|2017|404
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289
The World Health Organization 2016 classification of testicular non‐germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel
|Histopathology|2016|236
Frequent <i>FGFR3</i> mutations in urothelial papilloma
|The Journal of Pathology|2002|189